We’re building a Commons so that patients, physicians, and scientists can seamlessly learn and benefit from the latest outcomes of innovative treatments
Advanced cancer is personal, but you don’t have to face it alone. Our experts review your medical records and work with you to find your best treatment options
News & Events
In the next two decades, U.S. rankings of the most common and deadly cancer types will shift, reflecting the influence of screening programs and advancements in treatment. Lola Rahib, PhD, Director of Scientific and Clinical Affairs at Cancer Commons, led this research, which appears today in JAMA Network Open. The projections were prepared in collaboration with the Pancreatic Cancer Action Network (PanCAN) and The… Read more »
Cancer Commons founder Marty Tenenbaum, PhD, will join other leading innovators and experts next week as a panelist at the 2021 virtual Precision Medicine World Conference (PMWC). This year’s theme is “21st Century Precision Medicine in the Age of COVID-19.” On Monday, Jan 25, at 1pm PST, Marty will engage with other distinguished panelists in an exploration of how to make clinical trials more accessible… Read more »
Despite 2020 creating some of the most difficult circumstances of our lifetimes, it was a year of progress for Cancer Commons. Cancer Commons’ Model Validated Cancer Commons helps patients and their physicians collectively explore the latest and best treatment options far more efficiently than they can as individuals, often via a “molecular tumor board” model that precisely matches patients to personalized options. We recently… Read more »
Our network brings together leading cancer experts, including physicians, clinical researchers, and laboratory scientists
What I appreciate the most about Emma is her human goodness and empathy. I have never felt I was just a case for her.
Cervical cancer survivor
My experience with Cancer Commons has been fantastic! Their support and advice have been extremely helpful. I will always be very greatful to the Cancer Commons team. They took the time to contact me by phone to learn more about my diagnosis so they could study my case and recommend options to consider. Thanks so much to all the people involved.
Grade 4 glioblastoma patient
Cancer Commons’ scientists and doctors were very helpful in identifying possible clinical trials for our son’s rare brain tumor.
Mother of brain tumor patient
I am grateful for the concise and accurate summary of my treatment options. I have been waiting 3 years for this. Your goal to close the gap between metastatic trials and patients holds great promise to speed up success.
My contact was prompt, professional, and kind. Cancer Commons helped me review my options going forward.